transthyretin

Jul 06, 2020
Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review
Importance: Many patients with systemic amyloidosis are underdiagnosed. Overall, 25% of patients with immunoglobulin light chain (AL) amyloidosis die within 6…
Read more
Mar 14, 2019
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy
Background: Transthyretin (TTR) amyloidosis is an underdiagnosed disease caused by destabilization of TTR due to pathogenic mutations or aging. Both pathogenic and…
Read more
European Journal of Human Genetics
Mar 21, 2017
From older to younger: intergenerational promotion of health behaviours in Portuguese families affected by familial amyloid polyneuropathy
The role of older generations in families with hereditary diseases has been recognised and associated to their function as guardians of the family's medical history…
Read more
Sep 19, 2016
Identification of Prognostic Markers in Transthyretin and AL Cardiac Amyloidosis
Background: The prognosis of amyloidosis is known to depend heavily on cardiac function and may be improved by identifying patients at highest risk for adverse…
Read more
Sep 13, 2016
Liver Transplantation in Transthyretin Amyloidosis: Characteristics and Management Related to Kidney Disease
Orthotopic liver transplantation (LT) was implemented as the inaugural disease-modifying therapy for hereditary transthyretin (ATTR) amyloidosis, a systemic…
Read more
May 16, 2016
Transthyretin Cardiac Amyloidosis in Black Americans
Transthyretin-related cardiac amyloidosis is a progressive infiltrative cardiomyopathy that mimics hypertensive and hypertrophic heart disease and often goes…
Read more
Subscribe to